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Asymptomatic Plasmodium falciparum 
infections may not be shortened by acquired 
immunity
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Abstract 
Background: The duration of untreated Plasmodium falciparum infections is a defining characteristic of the parasite’s 
biology. It is not clear whether naturally acquired immunity (NAI) can shorten infections, despite the potential implica‑
tions for malaria control and elimination as well as for basic research.
Methods: Data on the presence of P. falciparum msp2 genotypes in six blood samples collected over one year was 
analysed, together with four samples collected over 1 week, from a cohort in Navrongo (Ghana). Mathematical mod‑
els assuming either exponential, Weibull, gamma, or log‑normal infection durations were estimated separately for six 
age‑groups. The method allowed for varying clonal acquisition and detection rates.
Results: The best fitting (Weibull) mean durations were 124 days (children <5years old), 179 days (5–9 years), and 
70–90 days (>10 years). This non‑monotonic age pattern is not suggestive of an infection‑clearing effect of NAI since 
immunity increases with exposure, and thus, age. Age‑related differences in innate immunity are a more plausible 
explanation. 21% of blood‑stage infections terminated within 1 week, in stark contrast to months of persistence in 
infections induced in neuro‑syphilis patients (malariatherapy data). Age independence in this percentage raises the 
possibility that this clearance may result from innate mechanisms or genetic incompatibility between hosts and para‑
sites, rather than from NAI.
Conclusion: In all ages of hosts a substantial proportion of infections are cleared in the first days or weeks of appear‑
ance in the blood, while others persist for many months. Although cumulative exposure and NAI increase with age, 
this does apparently not translate into an increased rate of termination of infections.
Keywords: Plasmodium falciparum, Malaria, Immunity, Duration of infection, Mathematical model, Immigration‑
death model, Merozoite surface protein 2, Detectability, Cohort study
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Background
Malaria caused by Plasmodium falciparum continues 
to be among the top global public health problems. It 
causes an estimated 560,000 fatalities per year, mostly 
children under 5 years of age [1]. The parasite has many 
immune-evasion mechanisms: it displays extensive anti-
genic diversity, is able to switch between surface antigen 
variants, and several parasitic stages in the human host 
are poorly immunogenic [2]. How naturally acquired 
immunity (NAI) affects the duration of blood-stage 
infections is not well understood. It has been theorized 
that the duration of infections might be longer in rela-
tively immune individuals, rather than shorter [3]. A bet-
ter understanding of the epidemiological effects of NAI 
against malaria is warranted to guide efforts to control 
and potentially eliminate the disease. Moreover, knowl-
edge of both effects and mechanisms of NAI is key to 
designing highly effective malaria vaccines.
Information on the effects of NAI can be obtained 
from (observational) epidemiological data by interpret-
ing changing infection and disease patterns in response 
to exposure. Cumulative exposure (the total number of 
Open Access
*Correspondence:  thomas‑a.smith@unibas.ch 
2  University of Basel, Basel, Switzerland
Full list of author information is available at the end of the article
Page 2 of 10Bretscher et al. Malar J  (2015) 14:294 
infections experienced by an individual) is proportional 
to host age for a given transmission intensity. This holds 
true even in the presence of spatial transmission het-
erogeneity. Consequently, age can be used as proxy for 
NAI. Analyses using this approach suggested that pro-
tection against non-cerebral severe malaria is acquired 
very quickly, after one or two infections [4]. NAI does 
not protect from re-infection with malaria, at least not 
completely, since many older individuals carry parasites 
even in areas of highest transmission intensity. Infec-
tions in such highly exposed individuals, however, are 
mostly asymptomatic, indicating a protective effect of 
NAI against clinical episodes [5]. Immune hosts gener-
ally have lower parasite counts and many of the clinical 
manifestations of malaria—fever, severe malaria, anae-
mia—can be directly related to high parasite densities 
[5, 6]. Therefore, the impact of NAI is most parsimoni-
ously summarized as an improved ability to control para-
site densities [5]. An important consequence of reduced 
parasite densities in immune individuals is reduced 
diagnostic sensitivity: parasites are hard to detect when 
present at low numbers, because too few parasites may 
be present in the blood sample analysed. This limitation 
not only affects microscopy but also methods based on 
Polymerase Chain Reaction (PCR), despite their substan-
tially increased sensitivity. Here, the term “detectability” 
is used to describe the probability of detecting a particu-
lar infecting clone conditional on it being present in the 
host. This is similar to “sensitivity” but emphasizes host 
and parasite factors rather than the quality of a diagnos-
tic test. The consequences of this detectability-reducing 
effect of NAI for the interpretation of epidemiological 
data are profound: it leads to uncertainty about whether 
exposure-related trends in malaria prevalence are due 
to reduction in acquisition of new infections, shorter 
infection durations, or merely due to lower detectabil-
ity. Consequently, obtaining information on the effect of 
immunity on infection durations from epidemiological 
data is not straightforward. Historically this led to false 
confidence that an important effect of NAI is to sig-
nificantly shorten P. falciparum infections[7]. For non-
immune individuals, information on infection durations 
can be obtained from malaria therapy data. These data 
stem from patient records of the pre-antibiotic era, where 
malaria-induced fevers were used to treat neurosyphi-
lis. The therapeutic infections lasted about 210  days on 
average and very short or very long durations were rare 
[8]. Malaria therapy data only contain information on 
infection durations in subjects with little or no previous 
exposure but remain the most important source of infor-
mation on P. falciparum in-host dynamics. It is important 
to fill this knowledge gap by analyzing infection clearance 
in naturally exposed populations.
Multiple concurrent blood-stage infections within 
one human host are common in high-transmission set-
tings since NAI does not protect from re-infection. How 
long the individual clones persist, how they interact with 
each other, and how their durations are affected by NAI 
is not well understood. Different infecting clones can be 
distinguished by genotyping parasite DNA from blood 
samples using highly polymorphic molecular markers. 
Provided high marker diversity in the parasite popula-
tion the multiplicity of infection (MOI, number of co-
infections) can be determined as the number of distinct 
PCR fragment sizes per sample. Age trends in such MOI 
measurements, however, do not directly reveal the effects 
of NAI on infection clearance—because clonal detect-
ability itself declines with immunity [9]; this is analogous 
to the interpretation of age trends in microscopy preva-
lence explained above. To estimate duration from geno-
typing data, individual parasite clones must be tracked 
over time, in repeated samples (cohort studies). However, 
simply recording the time between first and last appear-
ance of a genotype as estimate of infection duration gives 
false results: due to the low detectability it is impossible 
to tell for how long a genotype was already present before 
the first detection, and for how long it persisted after the 
last one. In extreme cases, start and endpoints of infec-
tion may well be before and after the study, respectively. 
Consequently, specialized statistical models must be used 
which simultaneously estimate force of infection, dura-
tion and detectability parameters. “Immigration-death” 
(ID) stochastic models [10] satisfy this requirement. To 
further gain insight on the effects of NAI on infection 
clearance, the data must comprise hosts of all ages, such 
that age trends can be interpreted. To the authors’ best 
knowledge only a single dataset is available which meets 
these criteria for investigating the effect of immunity 
on infection clearance: a cohort study from Navrongo, 
Northern Ghana, where individual clones were tracked 
longitudinally in two-monthly samples by identifying 
alleles at the highly polymorphic locus “Merozoite Sur-
face Protein 2” (msp2) [11].
A number of articles have used the Navrongo dataset 
to assess the persistence of individual clones using sta-
tistical models that allow for imperfect parasite detec-
tion [9, 10, 12–15]. Of these, [15] and [9] are the most 
recent. Felger et  al. [9] modelled infection clearance 
using exponential distributions, thereby estimating the 
mean duration of clonal infections separately for differ-
ent age groups. The duration was found to be higher in 
1–9 year old children (between 196 and 319 days) than 
in individuals below one and above 10  years (between 
130 and 155  days). No decreasing trend with host age, 
and by implication exposure, was observed. Clonal 
detectability was found to decrease monotonically from 
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about 50% in young children to approximately 10% in 
older adults. No decrease of the force of infection (FOI, 
no. of blood stage infections acquired per person per 
year) with host age was observed as would be expected 
if infection-blocking immunity were gradually build-
ing up over time [9]. Taken together, these results imply 
that (1) NAI does not decrease the average duration of 
clonal infections, (2) NAI does most likely reduce the 
clonal detectability, (3) no additional infection-block-
ing immunity is acquired compared to the youngest 
age group, even after decades of exposure, and (4) the 
observed age-decrease in PCR prevalence and MOI in 
the dataset must be caused by a decrease of detectabil-
ity alone, because both FOI as well as duration (which 
together determine the proportion infected) do not 
decrease with age.
An important limitation of using an exponential dis-
tribution as model for infection clearance is that only 
the mean duration is estimated. No information can be 
obtained on whether—for example—all infections are 
cleared exactly on the day corresponding to the average 
duration or if the estimated average in fact arises from 
different subpopulations with short and long durations. 
The reason why most disease models assume exponen-
tial clearance of infections is because it simplifies the 
required mathematics enormously. A method for using 
Weibull, lognormal or gamma survival distributions 
([15], Table 1) to analyse the Navrongo dataset was devel-
oped previously.
The obtained estimates revealed a large proportion of 
very short infections, lasting only days or a few weeks. 
This is very different from malaria therapy data where 
most infections lasted several months if not treated. Also 
the average duration of blood-stage infections measured 
by [15] was lower (140 days) than in malariatherapy data 
(210 days) [8]. Transmission intensity is very high in Nav-
rongo, estimated at 200–600 infectious mosquito bites 
per year [16]. Therefore, the abundance of very short 
infections and a shortened average duration in [15] may 
be interpreted as a saturation phenomenon at the blood-
stage level.
The objective of the present analysis is to better under-
stand the results of [15] in two ways. Firstly, more accu-
rate information on the frequency and durations of 
short infections will be obtained by analyzing data with 
sampling intervals of one to five days. These samples, 
described in [17], were collected from the same hosts 
immediately after the two-month samples used by [9, 15]. 
Secondly, it will be investigated whether NAI can explain 
in the clearance of the shortest blood-stage infections, by 
estimating the distribution of infection durations sepa-
rately for different age groups. Should immunity acquired 
over years of exposure be involved, then short infec-
tions are expected to be rare in young individuals and to 
increase with host age.
Methods
The field study, conducted in the Kassena-Nankana dis-
trict in the upper East region of Ghana was described 
previously [10, 14, 18, 19]. The malariological situation 
in this area is characterized by very high prevalence and 
multiplicity of infection [18, 20], and year-round trans-
mission with seasonal variation in intensity [14].
Study design and analysis methods
Blood was collected on ISOCodeStix™ PCR template 
preparation dipsticks (Schleicher & Schuell, Dassel, Ger-
many). The study design comprised two distinct schemes 
for sample collection: firstly, a total of 349 individuals of 
all ages were visited every 2  months over the period of 
1 year. Participants were chosen from randomly selected 
compounds in the study area, in an age-stratified man-
ner [18]. This yielded the “long-interval” data, which was 
analysed using a previously described statistical method 
[15]. From the 349 participants of the main study, 80 
individuals below 20 years of age were randomly selected 
for further sampling at shorter time intervals. Three addi-
tional blood samples were taken at day one, six and seven 
Table 1 Mathematical models for clearance of infections
Infection durations were modelled using parametric survival distributions. The exponential distribution is specified by a single scale parameter (the mean duration 
of infection). All the others have increased flexibility due to an additional shape parameter (distribution-specific parameter names are ignored). The following 
abbreviations are used in the table: for the gamma function Ŵ(z) =
∫∞
0 t
z−1e−t dt, for the lower incomplete gamma function γ (s, x) =
∫ x
0 t
s−1 e−t dt, and for the error 
function erf(x) = 2√
π
∫ x
0 e
−t2dt.
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after the last survey of the main study. Study partici-
pants were visited in the early mornings of each day and 
houses were visited in the approximately the same order, 
to ensure sample collection at roughly the same time of 
day for each individual. These additional three samples 
in conjunction with the last sample from the main study 
constitute the “short-interval” data, which had been used 
previously for the measurement of detectability [17]. The 
present analysis aims to confirm the presence of short 
infections by taking advantage of the high time-resolu-
tion of these data.
Genotyping
DNA was eluted from ISOCodeStix™ Stix and screened 
for presence of P. falciparum by nested msp2 PCR. Pro-
cessing of stix and PCR conditions have been described 
in detail before [21]. Alleles of the length-polymorphic 
genotyping marker msp2 were distinguished by capillary 
electrophoresis and GeneMapper® software. An in-house 
generated software facilitated further analysis of Gen-
eMapper® output and transformed the data into formats 
suitable for data management and statistical analysis.
Analysis of short interval data
Data from those 69 participants out of 80 with a com-
plete set of four samples were analysed. The statistical 
analysis considered the presence of a decreasing time 
trend in the probability of detection of an individual 
clone. Taking as reference the sample where a clonal 
infection first appeared, a data point was generated for 
every subsequent sample by noting whether the genotype 
was detected again or not. The probability of re-detection 
after t days was modelled as p = qe−µt, with clearance 
parameter µ and detectability q. This can be interpreted 
as q multiplied by the probability that a clone is not yet 
after t days, as given by the exponential survivor function 
e−µt. The parameters µ and q were estimated by fitting 
the linearized model ln(q)− µt using the glm function in 
R, assuming a Bernoulli error model and a log link func-
tion. This model was compared via a likelihood-ratio test 
against a null model with time-invariant detection prob-
ability q.
Analysis of long interval data
The six blood samples per person from the main study, 
obtained in intervals of 2  months, were analysed using 
immigration-death models which allowed for non-expo-
nential distributions of infection durations, as described 
earlier [15]. In short: after preparation of the data into 
suitable format, statistical models which simulate acqui-
sition, loss and detection of clonal infections were fitted. 
Corresponding to the three simulated processes, three 
sets of parameters were estimated: the FOI parameters , 
the scale and shape parameters of the distribution consti-
tuting the model for infection clearance (r and s, respec-
tively), and the detectability parameters q.
Data preparation
Only data of those participants who were present at all 
six survey rounds of the main study were included in the 
analysis. This reduced the number of individuals in the 
dataset to 216. Failure or success to detect a genotype 
was denoted by 0 or 1, respectively, giving rise to 63 pos-
sible types of longitudinal patterns of detection, contain-
ing at least one positive test result. These were numbered 
from one to 63 using their binary value (e.g., 000010 is 
pattern 2), and counted. Thus, for every host, a frequency 
distribution of binary patterns was obtained. Statisti-
cal models were formulated to predict the absolute fre-
quency of each pattern, taking into account host age and 
seasonal transmission.
Immigration‑death models
New parameterizations of previously described immigra-
tion-death models were fitted to the long-interval data 
[15]. These models simulate acquisition (since birth), loss 
and detection of clonal infections, using a FOI parame-
ter , shape (s) and scale (r) parameters of a distribution 
of infection durations, and a probability of detection, 
q. Given model equations for these basic parameters of 
infection dynamics, the expected frequency distribu-
tion of binary patterns in a given host can be predicted, 
and a likelihood can be calculated. The following model 
parameterizations were used: for the time-dependent 
FOI parameter (t) it was assumed that a pattern of sea-
sonal transmission had repeated since the birth of every 
host, with the FOI being independent of host age. Con-
sequently, the model estimated six seasonal FOI param-
eters, each one corresponding to the acting FOI between 
two survey rounds.
Clearance of infections was modelled using four para-
metric survival distributions: the exponential, Weibull, 
gamma and lognormal distributions (Table  1). These 
represent competing hypotheses about infection clear-
ance, compared with respect to goodness of fit. The 
exponential distribution is characterized by a single scale 
parameter r, equal to the mean duration of a clonal infec-
tion. It does therefore not have any flexibility to yield 
detailed information on the properties of the clearance 
process. Nevertheless it has been widely used in infec-
tious disease models, mainly due to it’s mathematical 
simplicity (assuming a constant clearance rate per time 
implies an exponential distribution of infection durations 
and makes it possible to ignore the age structure of the 
within-host infection population). The Weibull, lognor-
mal and gamma distributions are characterized by two 
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parameters, r and s. In the following these will be called 
“scale” and “shape” parameters, ignoring possible distri-
bution-specific names. A separate set of scale and shape 
parameters was estimated for each of the following age 
groups (in years): <5, 5–9, 10–19, 20–39, 40–59, ≥60. 
This extension of previous analyses [15], which estimated 
a single parameter set over all ages, serves the purpose 
of investigating a dependence of infection clearance on 
previous exposure, and by implication, acquired immu-
nity. The detectability parameter q was modelled as a 
logit-linear function of host age. For a host of given age 
a (in units of two months) the detectability can be cal-
culated as q(a) = logit −1(q0 + q1(a− a¯)), with average 
age a¯ = 120.72 and estimated parameters q0 and q1. A 
detailed description of the statistical methods was given 
previously, and all models were implemented in the Java ™ language and fitted to the data by maximum likelihood, 
as described in [15].
Results
Two sets of longitudinal msp2 genotyping data were ana-
lysed using mathematical models that allow for imperfect 
detection of parasites. Both data sets stem from the same 
cohort study, but samples were collected at different time 
intervals. The “long-interval data”, with two-monthly 
sample collection and age-stratified study popula-
tion, was analysed using non-exponential ID models as 
developed in [15]. This yielded estimates of the rates of 
acquisition, clearance, and detection of parasite clones, 
and how these parameters are influenced by host age, a 
proxy for immunity. The “short-interval data” comprised 
four samples collected within one week from individuals 
below 20 years (median age 5.2 years, inter-quartile range 
3.5–9.7) [17]. This permitted a detailed investigation of 
the shortest infections in moderately exposed individuals 
of the Navrongo population.
Parasite acquisition, clearance and detection in the 
long‑interval data
A comprehensive epidemiological description of the 
long-interval genotyping data was given in [9]. The aver-
age prevalence of P. falciparum was 48% by microscopy 
and 75% by PCR. Positivity by PCR showed a peak in the 
5–9  year old children with 93% and declined to 54% in 
individuals older than 60 years. Mean multiplicity meas-
ured in the PCR positive samples also peaked in the age 
group of 5–9 years at 6.9 and was lowest in the 60+ age 
group at 2.8 distinct alleles per person. A total of 103 dif-
ferent msp2 genotypes were found, the most frequent 
genotype representing 10.2% of all fragments detected. 
In the present analysis of the long-interval data, four ID 
models, using distinct parametric survival distributions 
to describe clearance of clonal infections, were compared 
using Akaike’s Information Criterion (AIC) as a measure 
of goodness of fit (Tables  2, 3): the Weibull model very 
clearly fitted the data best (AIC: 7908.5), followed by 
Table 2 Raw parameter estimates: force of infection and detectability
Separate FOI parameters (1, 2, . . . , 6) were estimated for each of the six 2-month seasons. For a host of given age a (in units of two months) the detectability can be 
calculated as q(a) = logit −1(q0 + q1(a− 120.72)). Lower AIC values indicate a better fit to the data.
Survival model FOI by season (person‑1 year‑1) Detectability AIC
1 2 3 4 5 6 q0 q1 (2‑months‑1)
Weibull 74.5 41.6 36.3 13.2 22.7 56.9 −0.72 −0.003727 7,908.5
Gamma 169.1 93.5 89.2 9.1 57.1 126.3 −0.84 −0.004692 7,944.8
Lognormal 41.7 26.0 21.6 7.5 15.1 38.8 −0.89 −0.004985 7,978.3
Exponential 45.1 19.3 18.1 7.4 12.3 39.8 −0.84 −0.002865 8,022.6
Table 3 Raw parameter estimates: clearance of infections
Parameter estimates are shown for all models and host age groups. The exponential distribution is defined by a single “scale” parameter per age group, while all other 
distributions require an additional “shape” parameter. Derived measures, such as the mean duration, are obtained in conjunction with the equations in Table 1. The 
survey interval of two months was used as time unit where applicable. Lower AIC values indicate a better fit to the data.
Survival model Scale Shape AIC
r1 r2 r3 r4 r5 r6 s1 s2 s3 s4 s5 s6
Weibull 1.00 1.31 1.01 0.75 0.94 1.23 0.49 0.47 0.67 0.58 0.66 0.75 7,908.5
Gamma 9.02 12.37 6.24 6.64 7.06 8.44 0.10 0.10 0.12 0.09 0.10 0.12 7,944.8
Lognormal 1.68 1.86 1.54 1.51 1.62 1.71 1.32 1.37 1.06 1.06 1.18 1.24 7,978.3
Exponential 3.73 5.30 2.93 2.15 2.10 2.18 – – – – – – 8,022.6
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the gamma (AIC: 7944.8), lognormal (AIC: 7978.3), and 
exponential (AIC: 8022.6) models. The AIC values can be 
directly compared to those in [15] since the same dataset 
and methodology were used. The overall pattern of trans-
mission seasonality was consistent among all models of 
infection survival, but differences exist in the numerical 
estimates of the FOI (Fig.  1; Table  3). Estimates of the 
Weibull model ranged from 74.5 infections per person 
year in August and September to 13.2 infections in Feb-
ruary and March, while the corresponding results from 
the exponential model were 45.1 and 7.4, respectively. 
The gamma model estimated a considerably higher FOI 
of 169.1 in the high-transmission season, but the FOI 
estimate for the low-transmission season (9.1) agreed 
well with the other models. The raw parameter estimates 
describing a distribution of infection durations cannot 
easily be interpreted directly. Therefore, the mean dura-
tion is reported. It can be calculated from the scale and 
shape parameters (Table  3) and distribution-specific 
expressions (Table 1). All models suggested an intermedi-
ate mean duration of infection in the youngest age group, 
a peak in the 5–9 year olds and a subsequent decrease of 
duration with increasing host age (cumulative exposure).
A comparison of the best-fitting Weibull model with 
its age-independent counterpart in [15] found this age-
pattern to be significant (p < 0.0001, LR-test). The aver-
age durations across all age groups were (in days): 102.7 
(Weibull), 52.0 (gamma), 210.4 (lognormal), and 184.0 
(exponential). Results for all age groups separately are 
shown in Table 4 and Fig. 2. All models suggested that in 
all age groups a significant proportion of infections was 
cleared shortly after  appearance in the blood, as indi-
cated by a strong positive skew of the distributions of 
infection duration (see Additional file 1). The probability 
density functions (PDF) of the best-fitting Weibull model 
are shown in Fig. 3 for all age groups, alongside the PDF 
estimated from non-immune malaria therapy patients for 
comparison [8]. The exponential distribution, which is 
commonly used in disease models due to its simplicity, 
depends by definition entirely on the mean duration and 
does not have the flexibility to measure the proportion of 
short infections. It fitted the data less well than the other 
models. 
The estimates of detectability are in good quantitative 
agreement. All models measured a clonal detectability of 
ca. 40% in the young ages, which decreases to ca 20% in 
the older age groups (Fig. 4).
Clearance of the shortest infections
In the short-interval data, the average prevalence across 
all four survey rounds was 46% by microscopy and 69% 
by PCR [17]. The dataset comprised 69 parasite-positive 
individuals between 6 months and 20 years of age, with 
a median age of 5.2 years (inter-quartile range 3.5–9.7). 
The median MOI among PCR-positives was 4. The 519 
detected clones belonged to 77 different msp2 genotypes, 
with the most common allele reaching a frequency of 
9.2%. Fitting of the model p = qe−µt, which describes 
the probability of re-detection of a genotype after time t, 
yielded an estimate for detectability at 0.58 as well as an 
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Fig. 1 Seasonal Transmission. Each group of bars shows the FOI 
estimates for one 2‑month season. Estimates differ considerably 
depending on the mathematical model for infection clearance, but 
agree with respect to the pattern of seasonality. The Weibull model 
clearly gave the best fit to the data, thus yielding the most reliable 
estimates.
Table 4 Estimated mean duration of infections
The mean duration of infection (in days) is shown for all age groups and clearance models. It can be calculated from the parameter estimates (Table 3) and the 
distribution-specific expressions for the mean (Table 1). Lower AIC values indicate a better fit to the data.
Survival model <5 years old 5–9 years old 10–19 years old 20–39 years old 40–59 years old >60 years old AIC
Weibull 124.2 178.8 80.2 70.2 75.3 87.7 7,908.5
Gamma 54.6 77.4 43.1 36.8 40.6 59.7 7,944.8
Lognormal 241.9 285.5 161.7 158.4 194.6 220.4 7,978.3
Exponential 224.1 317.9 175.6 128.8 126.3 131.4 8,022.6
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estimated clearance rate of 0.0033 per day (p < 0.001, LR 
test). This corresponds to 3% of infections being cleared 
per day, or 21% per week (Fig. 5).
Discussion
The Navrongo long-interval data used in this work is 
unique in that it combines an age-stratified study design 
with high-resolution genotyping data and longitudinal 
follow-up of individuals. These features make it possi-
ble to gain detailed insight into the clearance of natural 
blood-stage infections, how this changes with host age, 
and how it compares to infection clearance in the non-
immune, singly infected malariatherapy patients. Con-
sequently, the Navrongo data has been analysed with 
progressively more complex mathematical models [9, 
10, 14, 15]. The current analysis for the first time allows 
for non-exponential distributions of clearance times, 
permitting these distributions to vary with host age. 
The estimation of age-specific distribution parameters 
makes it possible to assess the effects of increasing expo-
sure (implicitly a proxy for NAI). Previous analyses were 
restricted to either non-exponential clearance [15] or age 
trends [9]. The best model fit, both in the present analysis 
as well as in comparison to all previous ID models in [9, 
14, 15], was obtained with Weibull-distributed clearance 
times and separate parameters for each age group. 
According to this model, the average persistence of indi-
vidual clones peaked in 5–9  year olds, declined sharply 
after that, and did not further decrease with age (Fig. 2; 
Table  4). This statistically significant pattern is consist-
ent with NAI not having an effect on infection duration. 
Durations first increased with age in young children 
despite an increase in the cumulative number of experi-
enced infections with age. Similarly, decades of exposure 
in adults did not shorten infections any further. The non-
monotonic age pattern of average infection duration may 
better be understood as a consequence of age-related 
changes in the immune system rather than as an effect of 
cumulative exposure. It is known that parasite densities 
are controlled more stringently with increasing host age 
[22]. This is due to age-related changes in the immune 
system rather than as a consequence of exposure, and 
similar factors may influence the duration of infection. It 
appears that the age group from 5–9  years should con-
tribute more than others to the maintenance of malaria 
in regions with extended dry seasons, with their longer-
lasting infections having a higher chance of persisting to 
the next transmission season.
The historical malaria therapy data are still the best 
source of data on the course of single untreated P. falci-
parum infections due to the ethical limitations on obtain-
ing new, comparable data. Therefore it is necessary to 
discuss the present results in comparison to malaria ther-
apy data despite caveats of how representative those may 
be for malaria in general. Two major differences between 
infection durations in the Navrongo residents compared 
to the malaria therapy patients were reported previ-
ously: a shorter average infection duration, and a much 
higher frequency of very short infections [15]. The pre-
sent analysis of the Navrongo short interval data yielded 
more accurate information on the latter. It suggested that 
about one in five blood-stage infections in Navrongo 
were cleared within a week of appearance in the blood 
(Fig.  5). In contrast, few infections in the non-immune 
malaria therapy patients were cleared during the first 
weeks. Rather, the distribution of infection durations was 
approximately symmetrical about the mean [8, 23]. The 
somewhat shorter average duration in Navrongo together 
with the high frequency of very short durations consist-
ently point towards increased clearance during the early 
phase of a blood-stage infection (in the sense that a pro-
portion of short infections may explain a shorter aver-
age together with a second group of infections that last 
as long as those in the malaria therapy patients). It was 
hypothesized that this could be due to differences in 
immune status between patients and Navrongo residents 
[15]. According to this view, the highly exposed individu-
als in Navrongo might be immune against previously 
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Fig. 2 Effects of host age on the average infection duration. The 
average duration of clonal infections is shown against the midpoint 
of each age group and compared across clearance models. Lower AIC 
values indicate a better fit to the data. All models qualitatively agree 
with respect to the age pattern: an initial increase in duration during 
childhood, a sudden drop around the time of puberty, and no further 
decrease thereafter. The best‑fitting Weibull model estimates that 
average duration remains constant in adults at ca. 80 days, even after 
decade‑long exposure. Both the non‑monotonic changes during 
childhood and adolescence as well as the absence of a change in 
adults are consistent with NAI not acting to shorten infections.
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encountered genotypes, rapidly clearing these parasites 
with known antigenic profile from the blood. However, 
all ID models, including the best-fitting Weibull model, 
estimated that infections of short duration are similarly 
frequent in all age groups in Navrongo. This means that 
neither immunity acquired through years of exposure 
nor intrinsic age dependency in host responses can be 
important clearance promoting factors. An involvement 
of NAI would imply that short infections should become 
progressively more frequent in the older age groups. 
Provided, of course, that children in the youngest age 
group have not yet acquired infection-clearing immu-
nity against all antigenic variants in circulation, which 
appears rather unlikely.
While a simple relationship between NAI and infec-
tion clearance is not apparent in the present results, it 
is difficult to identify the reasons behind the differences 
in infection clearance between Navrongo residents and 
malaria therapy patients. The shorter average duration 
in Navrongo together with the high frequency of short 
infections in all age groups is consistent with clearance by 
innate (non-specific) mechanisms which are independent 
of cumulative exposure. Almost all parasites in Navrongo 
meet the human host already occupied upon inoculation, 
while the malaria therapy patients were singly infected. A 
plausible cause for the rapid infection clearance in Nav-
rongo may therefore be cross-reactive, transient host 
responses stimulated by high densities of one clone but 
acting against all co-infections [24]. Several experiments 
in non-falciparum animal models show that pre-existing 
infections can block the acquisition of new clones [25–
27]. In humans, protection from clinical episodes as well 
as from superinfection due to pre-existing P. falciparum 
infections in humans has been documented [28–31]. 
Fig. 3 Short infections are similarly common in all age groups. The distribution of infection durations in Navrongo as estimated by the best‑fitting 
Weibull model is illustrated for all age groups separately. Short infections are similarly common in all age groups, as indicated by the left‑skewed 
PDF. An estimate from non‑immune adult malaria therapy patients, where short infections are rare, is shown for comparison [8]. Mean durations are 
indicated by circles on the abscissa. If infections were cleared shortly after inoculation because of host immunity against particular antigenic variants 
one would expect an increase in the proportion of short infections with host age, a proxy for cumulative exposure.
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Confirmation of this hypothesis, however, may require 
data where durations in singly and multiply infected 
hosts could be compared, perhaps from areas with lower 
transmission intensity or after radical parasite cure. 
Without such additional information, several alternative 
explanations cannot be excluded with certainty. Host- or 
parasite genetics could play a role [32] or differences in 
infective route and dose (some malaria therapy patients 
were infected using sporozoites, either through mosquito 
bites or via subcutaneous injection, and others through 
infected blood [8, 33]). One can be confident, however, 
that the frequency of short infections does not indicate 
unreported treatment among Navrongo residents: older 
individuals in such highly endemic areas are rarely symp-
tomatic and consequently do not self-treat. One would 
thus expect short infections to be common among chil-
dren, but very rare among adults.
The finding that cumulative exposure does not have an 
easily identifiable effect on infection clearance is some-
what counterintuitive. It appears plausible that the par-
asite may have evolved a strategy to prevent the human 
immune system from getting better at clearing infections 
with cumulative exposure. The difficulty in explaining the 
patterns of infection clearance in Navrongo illustrates the 
incompleteness of the scientific understanding of malaria 
in-host dynamics in naturally exposed populations.
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Fig. 5 The probability of re‑detecting clonal infections decreases 
with time. Shown is the probability that a genotype present in the 
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